October 2025 in “Frontiers in Immunology” The document hypothesizes that platelet-rich plasma (PRP) could be an effective adjunct therapy for eczema by addressing inflammation, repairing the skin barrier, and reducing chronic recurrence. Eczema involves immune dysregulation and barrier dysfunction, and current treatments often have side effects or limited efficacy. PRP, which contains growth factors and bioactive molecules, has shown promise in treating conditions like alopecia areata and psoriasis, which share similarities with eczema. Despite the lack of systematic studies on PRP for eczema, its safety profile and potential to modulate immune responses and enhance barrier function suggest it could be beneficial, warranting further clinical trials.
68 citations
,
March 2019 in “Advanced Healthcare Materials” Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.
3 citations
,
October 2010 in “Epilepsy Currents” Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.
October 2010 in “Epilepsy Currents” Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.
100 citations
,
May 2011 in “Journal of Pediatric and Adolescent Gynecology” The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.